Page last updated: 2024-08-24

ranolazine and Eulenburg Disease

ranolazine has been researched along with Eulenburg Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Arnold, WD; Barohn, RJ; Cannon, SC; Fontaine, B; Griggs, RC; Hanna, MG; LoRusso, S; Matthews, E; Meola, G; Sansone, VA; Statland, JM; Stunnenberg, BC; Trivedi, JR; van Engelen, BGM; Vicart, S1
Agriesti, J; Bartlett, A; David Arnold, W; Freimer, M; Hawash, AA; Kissel, JT; Kline, D; Lorusso, S; Rich, MM1

Reviews

1 review(s) available for ranolazine and Eulenburg Disease

ArticleYear
Guidelines on clinical presentation and management of nondystrophic myotonias.
    Muscle & nerve, 2020, Volume: 62, Issue:4

    Topics: Acetazolamide; Age of Onset; Carbonic Anhydrase Inhibitors; Chloride Channels; Electrodiagnosis; Electromyography; Fatigue; Genetic Testing; Humans; Lamotrigine; Mexiletine; Muscle Weakness; Muscle, Skeletal; Myalgia; Myotonia Congenita; Myotonic Disorders; NAV1.4 Voltage-Gated Sodium Channel; Practice Guidelines as Topic; Ranolazine; Sodium Channel Blockers; Voltage-Gated Sodium Channel Blockers

2020

Other Studies

1 other study(ies) available for ranolazine and Eulenburg Disease

ArticleYear
Open-label trial of ranolazine for the treatment of paramyotonia congenita.
    Muscle & nerve, 2019, Volume: 59, Issue:2

    Topics: Adult; Electromyography; Female; Hand Strength; Humans; Male; Middle Aged; Muscle Weakness; Myotonic Disorders; Pain; Ranolazine; Severity of Illness Index; Sodium Channel Blockers; Stiff-Person Syndrome

2019